SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-14-024385
Filing Date
2014-04-24
Accepted
2014-04-23 19:26:50
Documents
1
Group Members
KENILWORTH VENTURES, INC. PROFIT SHARING PLAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v375661_sc13da.htm SC 13D/A 67511
  Complete submission text file 0001144204-14-024385.txt   69137
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 14779828
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 SOUTH POINTE DRIVE UNIT 2405 MIAMI BEACH FL 33139
Business Address
Zocchi NIcholas J. (Filed by) CIK: 0001548656 (see all company filings)

Type: SC 13D/A